NEPHROS INC's ticker is NEPH and the CUSIP is 640671400. A total of 17 filers reported holding NEPHROS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 1.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $22,632 | -4.5% | 15,292 | 0.0% | 0.00% | – |
| Q2 2023 | $23,703 | +44.9% | 15,292 | 0.0% | 0.00% | – |
| Q1 2023 | $16,361 | -7.5% | 15,292 | 0.0% | 0.00% | – |
| Q4 2022 | $17,696 | +26.4% | 15,292 | 0.0% | 0.00% | – |
| Q3 2022 | $14,000 | -50.0% | 15,292 | -16.2% | 0.00% | – |
| Q2 2022 | $28,000 | -15.2% | 18,254 | +142.6% | 0.00% | – |
| Q1 2022 | $33,000 | -13.2% | 7,525 | +16.2% | 0.00% | – |
| Q4 2021 | $38,000 | -68.6% | 6,476 | -53.2% | 0.00% | – |
| Q3 2021 | $121,000 | +146.9% | 13,837 | +186.3% | 0.00% | – |
| Q2 2021 | $49,000 | +96.0% | 4,833 | +26.7% | 0.00% | – |
| Q1 2021 | $25,000 | -24.2% | 3,815 | 0.0% | 0.00% | – |
| Q4 2020 | $33,000 | +17.9% | 3,815 | 0.0% | 0.00% | – |
| Q3 2020 | $28,000 | -12.5% | 3,815 | 0.0% | 0.00% | – |
| Q2 2020 | $32,000 | +33.3% | 3,815 | 0.0% | 0.00% | – |
| Q1 2020 | $24,000 | – | 3,815 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Parkman Healthcare Partners LLC | 199,724 | $1,987,000 | 0.57% |
| INGALLS & SNYDER LLC | 134,539 | $1,339,000 | 0.07% |
| ELKHORN PARTNERS LIMITED PARTNERSHIP | 5,908 | $59,000 | 0.03% |
| B. Riley Wealth Advisors, Inc. | 14,254 | $142,000 | 0.01% |
| HighTower Advisors, LLC | 43,210 | $430,000 | 0.00% |
| BLAIR WILLIAM & CO/IL | 34,249 | $341,000 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 22,501 | $224,000 | 0.00% |
| DEUTSCHE BANK AG\ | 200 | $1,000 | 0.00% |
| BlackRock Inc. | 2,562 | $25,000 | 0.00% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 367 | $4,000 | 0.00% |